Please login to the form below

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE listing




Below are full profiles from other companies in this area

Company Details

Ig-Innovations

Telephone:+44 (0)1239 858972

Address:
Gernos
Maesllyn Llandysul
SA44 5LP

Latest content from PMHub

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change Wilmington Healthcare
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases. Blue Latitude Health
Ashfield Meetings & Events strengthens creative team following increase in requests to deliver global full service live events
Ashfield Meetings & Events (part of UDG Healthcare plc) has strengthened its UK creative team, as the largest event management agency specialising in the healthcare sector sees an increase in requests to deliver full service live events for global clients. Ashfield
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare that I come across what I would call a proper psychographic or ‘mindset’ segmentation. Instead, many marketers simply group customers into the brand adoption ladder or different levels of competitor loyalty – with mixed results. I spoke to Craig Galloway, an Associate Director of Marketing at Allergan on what he thinks the challenges are with implementing segmentation. Written by Paul Townley-Jones, Director of Brand & Strategy @ Page & Page Page & Page